Autoimmune Lymphoproliferative Syndrome
📧 Sign up to get email alerts when something new happens for Autoimmune Lymphoproliferative Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation [Phase 2]
A Phase 2 study evaluating allogeneic hematopoietic cell transplantation for disorders of T-cell proliferation and/or dysregulation, sponsor…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
A completed clinical trial evaluating fluorodeoxyglucose-positron emission tomography (FDG-PET) for evaluating autoimmune lymphoproliferativ…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS) [Phase 1, Phase 2]
A Phase 1/2 trial evaluated valproic acid (Depakote) for autoimmune lymphoproliferative syndrome (ALPS); the study has completed and results…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome [Phase 1]
Phase 1 trial of pyrimethamine for autoimmune lymphoproliferative syndrome has completed, sponsored by the National Institute of Allergy and…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome [Phase 1]
Phase 1 trial evaluating a pyrimethamine and sulfadoxine combination for autoimmune lymphoproliferative syndrome has completed, sponsored by…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.